Novo Nordisk
NVO
#21
Rank
โ‚น38.912 T
Marketcap
โ‚น8,572
Share price
-3.54%
Change (1 day)
4.14%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): โ‚น235.77

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น240.96. In 2022 the company made an earnings per share (EPS) of โ‚น183.13 an increase over its 2021 EPS that were of โ‚น167.99.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น235.7728.75%
2022โ‚น183.139.01%
2021โ‚น167.9915.08%
2020โ‚น145.9714.83%
2019โ‚น127.12-1.68%
2018โ‚น129.294.96%
2017โ‚น123.1831.08%
2016โ‚น93.98-10.33%
2015โ‚น104.8013.91%
2014โ‚น92.014.03%
2013โ‚น88.44-28.81%
2012โ‚น124.22108.9%
2011โ‚น59.4725.59%
2010โ‚น47.3535.01%
2009โ‚น35.07-9.17%
2008โ‚น38.6161.35%
2007โ‚น23.9328.96%
2006โ‚น18.5625.63%
2005โ‚น14.774.17%
2004โ‚น14.1813.55%
2003โ‚น12.4936.87%
2002โ‚น9.12-6.99%
2001โ‚น9.8121.56%
2000โ‚น8.0749.45%
1999โ‚น5.403.78%
1998โ‚น5.2012.15%
1997โ‚น4.6424.74%
1996โ‚น3.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น156.94-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น458.10 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น334.97 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น268.34 11.36%๐Ÿ‡ซ๐Ÿ‡ท France